Study of Tremelimumab Alone or Combined With Olaparib for Patients With Persistent EOC (Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Carcinoma)
Clinical trial NCT02485990 · TERMINATED
Trial details
- NCT number
- NCT02485990
- Sponsor
- Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2016-01-08
- Primary completion
- 2020-03-05
- Enrollment
- 24
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.